Recro Pharma Announces Pricing of Public Offering of Common Stock
December 13, 2016 09:09 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Dec. 13, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue-generating, specialty pharmaceutical company primarily focused on developing...
Recro Pharma Announces Proposed Public Offering of Common Stock
December 08, 2016 09:02 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Dec. 08, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam
November 28, 2016 07:00 ET
|
Recro Pharma, Inc.
IV Meloxicam Achieves Primary Endpoint of Statistically Significant Reduction in SPID24 in Patients with Acute Postoperative Pain Following Abdominoplasty SurgeryTen Secondary Endpoints Also...
Recro Pharma Reports Third Quarter 2016 Financial Results
November 10, 2016 07:00 ET
|
Recro Pharma, Inc.
Announced Positive Phase III Results from Pivotal Trial of IV Meloxicam Following Bunionectomy Surgery Pivotal Phase III Trial of IV Meloxicam Following Mini Abdominoplasty Surgery Ongoing;...
Recro Pharma to Present at Upcoming Investor Conferences
November 09, 2016 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
Recro Pharma Presents Clinical Data at PAINWeek 2016
September 07, 2016 16:05 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
September 06, 2016 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care...
Recro Pharma Announces Closing of Public Offering of Common Stock
August 19, 2016 10:38 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
Recro Pharma Announces Pricing of Public Offering of Common Stock
August 16, 2016 09:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
Recro Pharma Announces Proposed Public Offering of Common Stock
August 15, 2016 18:05 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...